Telomerase: Cellular immortalization and neoplastic transformation. Multiple functions of a multifaceted complex

Cytogenetic and Genome Research

Volumn 122, Issue 3-4, 2009, Pages 255-262

  Belgiovine, C ^a   Chiodi, I ^a   Mondello, C ^a  

^a CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

TELOMERASE;

CARCINOGENESIS; CELL AGING; CELL IMMORTALIZATION; CELL PROLIFERATION; CELL TRANSFORMATION; CHROMOSOME SIZE; ENZYME ACTIVITY; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SOMATIC CELL; TUMOR MODEL;

CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN; FEMALE; HUMANS; MALE; MODELS, GENETIC; NEOPLASMS; PROTEIN SUBUNITS; TELOMERASE; TELOMERE;

EID: 59649084635     PISSN: 14248581     EISSN: None     Source Type: Journal    
DOI: 10.1159/000167811     Document Type: Review

References (82)

1. Akimov SS, Ramezani A, Hawley TS, Hawley RG: Bypass of senescence, immortalization, and transformation of human hematopoietic progenitor cells. Stem Cells 23:1423-1433 (2005).
2. Alge CS, Hauck SM, Priglinger SG, Kampik A, Ueffing M: Differential protein profiling of primary versus immortalized human RPE cells identifies expression patterns associated with cytoskeletal remodeling and cell survival. J Proteome Res 5:862-878 (2006).
3. Artandi SE, Alson S, Tietze MK, Sharpless NE, Ye S, et al: Constitutive telomerase expression promotes mammary carcinomas in aging mice. Proc Natl Acad Sci USA 99:8191-8196 (2002).
4. Bagheri S, Nosrati M, Li S, Fong S, Torabian S, et al: Genes and pathways downstream of telomerase in melanoma metastasis. Proc Natl Acad Sci USA 103:11306-11311 (2006).
5. Blackburn EH, Greider CW, Szostak JW: Telomeres and telomerase: the path from maize, Tetrahymena and yeast to human cancer and aging. Nat Med 12:1133-1138 (2006).
6. Bocker W, Yin Z, Drosse I, Haasters F, Rossmann O, et al: Introducing a single-cell-derived human mesenchymal stem cell line expressing hTERT after lentiviral gene transfer. J Cell Mol Med 12:1347-1359 (2008).
7. Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, et al: Extension of life-span by introduction of telomerase into normal human cells. Science 279:349-352 (1998).
8. Burns JS, Abdallah BM, Guldberg P, Rygaard J, Schroder HD, Kassem M: Tumorigenic heterogeneity in cancer stem cells evolved from long-term cultures of telomerase-immortalized human mesenchymal stem cells. Cancer Res 65:3126-3135 (2005).
9. Campisi J, d'Adda di Fagagna F: Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol 8:729-740 (2007).
10. Cayuela ML, Flores JM, Blasco MA: The telomerase RNA component Terc is required for the tumour-promoting effects of Tert overexpression. EMBO Rep 6:268-274 (2005).
11. Chang MW, Grillari J, Mayrhofer C, Fortschegger K, Allmaier G, et al: Comparison of early passage, senescent and hTERT immortalized endothelial cells. Exp Cell Res 309:121-136 (2005).
12. Chapman EJ, Hurst CD, Pitt E, Chambers P, Aveyard JS, Knowles MA: Expression of hTERT immortalises normal human urothelial cells without inactivation of the p16/Rb pathway. Oncogene 25:5037-5045 (2006).
13. Cohen SB, Graham ME, Lovrecz GO, Bache N, Robinson PJ, Reddel RR: Protein composition of catalytically active human telomerase from immortal cells. Science 315:1850-1853 (2007).
14. Collins K: The biogenesis and regulation of telomerase holoenzymes. Nat Rev Mol Cell Biol 7:484-494 (2006).
15. Counter CM, Avilion AA, LeFeuvre CE, Stewart NG, Greider CW, et al: Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J 11:1921-1929 (1992).
16. d'Adda di Fagagna F, Reaper PM, Clay-Farrace L, Fiegler H, Carr P, et al: A DNA damage checkpoint response in telomere-initiated senescence. Nature 426:194-198 (2003).
17. Darbro BW, Lee KM, Nguyen NK, Domann FE, Klingelhutz AJ: Methylation of the p16(INK4a) promoter region in telomerase immortalized human keratinocytes co-cultured with feeder cells. Oncogene 25:7421-7433 (2006).
18. de Lange T: Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev 19:2100-2110 (2005).
19. Di Donna S, Mamchaoui K, Cooper RN, Seigneurin-Venin S, Tremblay J, et al: Telomerase can extend the proliferative capacity of human myoblasts, but does not lead to their immortalization. Mol Cancer Res 1:643-653 (2003).
20. Elstrom RL, Bauer DE, Buzzai M, Karnauskas R, Harris MH, et al: Akt stimulates aerobic glycolysis in cancer cells. Cancer Res 64:3892-3899 (2004).
21. Farwell DG, Shera KA, Koop JI, Bonnet GA, Matthews CP, et al: Genetic and epigenetic changes in human epithelial cells immortalized by telomerase. Am J Pathol 156:1537-1547 (2000).
22. Folini M, Berg K, Millo E, Villa R, Prasmickaite L, et al: Photochemical internalization of a peptide nucleic acid targeting the catalytic subunit of human telomerase. Cancer Res 63:3490-3494 (2003).
23. Gonzalez-Suarez E, Samper E, Ramirez A, Flores JM, Martin-Caballero J, et al: Increased epidermal tumors and increased skin wound healing in transgenic mice overexpressing the catalytic subunit of telomerase, mTERT, in basal keratinocytes. EMBO J 20:2619-2630 (2001).
24. Hahn WC, Counter CM, Lundberg AS, Beijersbergen RL, Brooks MW, Weinberg RA: Creation of human tumour cells with defined genetic elements. Nature 400:464-468 (1999).
25. Hahn WC, Dessain SK, Brooks MW, King JE, Elenbaas B, et al: Enumeration of the simian virus 40 early region elements necessary for human cell transformation. Mol Cell Biol 22:2111-2123 (2002).
26. Haker B, Fuchs S, Dierlamm J, Brummendorf TH, Wege H: Absence of oncogenic transformation despite acquisition of cytogenetic aberrations in long-term cultured telomerase-immortalized human fetal hepatocytes. Cancer Lett 256:120-127 (2007).
27. Harada H, Nakagawa H, Oyama K, Takaoka M, Andl CD, et al: Telomerase induces immortalization of human esophageal keratinocytes without p16INK4a inactivation. Mol Cancer Res 1:729-738 (2003).
28. Harley CB: Telomere loss: mitotic clock or genetic time bomb? Mutat Res 256:271-282 (1991).
29. Harley CB: Telomerase is not an oncogene. Oncogene 21:494-502 (2002).
30. Harley CB: Telomerase and cancer therapeutics. Nat Rev Cancer 8:167-179 (2008).
31. Herbert BS, Wright WE, Shay JW: p16(INK4a) inactivation is not required to immortalize human mammary epithelial cells. Oncogene 21:7897-7900 (2002).
32. Hooijberg E, Ruizendaal JJ, Snijders PJ, Kueter EW, Walboomers JM, Spits H: Immortalization of human CD8+ T cell clones by ectopic expression of telomerase reverse transcriptase. J Immunol 165:4239-4245 (2000).
33. Kang SS, Kwon T, Kwon DY, Do SI: Akt protein kinase enhances human telomerase activity through phosphorylation of telomerase reverse transcriptase subunit. J Biol Chem 274:13085-13090 (1999).
34. Kendall SD, Linardic CM, Adam SJ, Counter CM: A network of genetic events sufficient to convert normal human cells to a tumorigenic state. Cancer Res 65:9824-9828 (2005).
35. Kiyono T, Foster SA, Koop JI, McDougall JK, Galloway DA, Klingelhutz AJ: Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature 396:84-88 (1998).
36. Lee J, Sung YH, Cheong C, Choi YS, Jeon HK, et al: TERT promotes cellular and organismal survival independently of telomerase activity. Oncogene 27:3754-3760 (2008).
37. Li H, Zhou J, Miki J, Furusato B, Gu Y, et al: Telomerase-immortalized non-malignant human prostate epithelial cells retain the properties of multipotent stem cells. Exp Cell Res 314:92-102 (2008).
38. Li HM, Man C, Jin Y, Deng W, Yip YL, et al: Molecular and cytogenetic changes involved in the immortalization of nasopharyngeal epithelial cells by telomerase. Int J Cancer 119:1567-1576 (2006).
39. Li NF, Broad S, Lu YJ, Yang JS, Watson R, et al: Human ovarian surface epithelial cells immortalized with hTERT maintain functional pRb and p53 expression. Cell Prolif 40:780-794 (2007).
40. Li S, Rosenberg JE, Donjacour AA, Botchkina IL, Hom YK, et al: Rapid inhibition of cancer cell growth induced by lentiviral delivery and expression of mutant-template telomerase RNA and anti-telomerase short-interfering RNA. Cancer Res 64:4833-4840 (2004).
41. Li S, Crothers J, Haqq CM, Blackburn EH: Cellular and gene expression responses involved in the rapid growth inhibition of human cancer cells by RNA interference-mediated depletion of telomerase RNA. J Biol Chem 280:23709-23717 (2005).
42. Lindvall C, Hou M, Komurasaki T, Zheng C, Henriksson M, et al: Molecular characterization of human telomerase reverse transcriptase-immortalized human fibroblasts by gene expression profiling: activation of the epiregulin gene. Cancer Res 63:1743-1747 (2003).
43. Mahale AM, Khan ZA, Igarashi M, Nanjangud GJ, Qiao RF, et al: Clonal selection in malignant transformation of human fibroblasts transduced with defined cellular oncogenes. Cancer Res 68:1417-1426 (2008).
44. Masutomi K, Yu EY, Khurts S, Ben-Porath I, Currier JL, et al: Telomerase maintains telomere structure in normal human cells. Cell 114:241-253 (2003).
45. Masutomi K, Possemato R, Wong JM, Currier JL, Tothova Z, et al: The telomerase reverse transcriptase regulates chromatin state and DNA damage responses. Proc Natl Acad Sci USA 102:8222-8227 (2005).
46. Migliaccio M, Amacker M, Just T, Reichenbach P, Valmori D, et al: Ectopic human telomerase catalytic subunit expression maintains telomere length but is not sufficient for CD8+ T lymphocyte immortalization. J Immunol 165:4978-4984 (2000).
47. Milyavsky M, Shats I, Erez N, Tang X, Senderovich S, et al: Prolonged culture of telomerase-immortalized human fibroblasts leads to a premalignant phenotype. Cancer Res 63:7147-7157 (2003).
48. Mondello C, Scovassi AI: Telomeres, telomerase, and apoptosis. Biochem Cell Biol 82:498-507 (2004).
49. Mondello C, Chiesa M, Rebuzzini P, Zongaro S, Verri A, et al: Karyotype instability and anchorage-independent growth in telomerase-immortalized fibroblasts from two centenarian individuals. Biochem Biophys Res Commun 308:914-921 (2003).
50. Muntoni A, Reddel RR: The first molecular details of ALT in human tumor cells. Hum Mol Genet 14 Spec No. 2:R191-196 (2005).
51. Noble JR, Zhong ZH, Neumann AA, Melki JR, Clark SJ, Reddel RR: Alterations in the p16(INK4a) and p53 tumor suppressor genes of hTERT-immortalized human fibroblasts. Oncogene 23:3116-3121 (2004).
52. Ouellette MM, Aisner DL, Savre-Train I, Wright WE, Shay JW: Telomerase activity does not always imply telomere maintenance. Biochem Biophys Res Commun 254:795-803 (1999).
53. Perrem K, Colgin LM, Neumann AA, Yeager TR, Reddel RR: Coexistence of alternative lengthening of telomeres and telomerase in hTERT-transfected GM847 cells. Mol Cell Biol 21:3862-3875 (2001).
54. Petersen T, Niklason L: Cellular lifespan and regenerative medicine. Biomaterials 28:3751-3756 (2007).
55. Piao CQ, Liu L, Zhao YL, Balajee AS, Suzuki M, Hei TK: Immortalization of human small airway epithelial cells by ectopic expression of telomerase. Carcinogenesis 26:725-731 (2005).
56. Ramirez RD, Morales CP, Herbert BS, Rohde JM, Passons C, et al: Putative telomere-independent mechanisms of replicative aging reflect inadequate growth conditions. Genes Dev 15:398-403 (2001).
57. Ramirez RD, Sheridan S, Girard L, Sato M, Kim Y, et al: Immortalization of human bronchial epithelial cells in the absence of viral oncoproteins. Cancer Res 64:9027-9034 (2004).
58. Robertson DM, Li L, Fisher S, Pearce VP, Shay JW, et al: Characterization of growth and differentiation in a telomerase-immortalized human corneal epithelial cell line. Invest Ophthalmol Vis Sci 46:470-478 (2005).
59. Roy NS, Nakano T, Keyoung HM, Windrem M, Rashbaum WK, et al: Telomerase immortalization of neuronally restricted progenitor cells derived from the human fetal spinal cord. Nat Biotechnol 22:297-305 (2004).
60. Rufer N, Migliaccio M, Antonchuk J, Humphries RK, Roosnek E, Lansdorp PM: Transfer of the human telomerase reverse transcriptase (TERT) gene into T lymphocytes results in extension of replicative potential. Blood 98:597-603 (2001).
61. Schinzel AC, Hahn WC: Oncogenic transformation and experimental models of human cancer. Front Biosci 13:71-84 (2008).
62. Seger YR, Garcia-Cao M, Piccinin S, Cunsolo CL, Doglioni C, et al: Transformation of normal human cells in the absence of telomerase activation. Cancer Cell 2:401-413 (2002).
63. Serakinci N, Guldberg P, Burns JS, Abdallah B, Schrodder H, et al: Adult human mesenchymal stem cell as a target for neoplastic transformation. Oncogene 23:5095-5098 (2004).
64. Sharma GG, Gupta A, Wang H, Scherthan H, Dhar S, et al: hTERT associates with human telomeres and enhances genomic stability and DNA repair. Oncogene 22:131-146 (2003).
65. Shay JW, Pereira-Smith OM, Wright WE: A role for both RB and p53 in the regulation of human cellular senescence. Exp Cell Res 196:33-39 (1991).
66. Sherr CJ, DePinho RA: Cellular senescence: mitotic clock or culture shock? Cell 102:407-410 (2000).
67. Smith LL, Coller HA, Roberts JM: Telomerase modulates expression of growth-controlling genes and enhances cell proliferation. Nat Cell Biol 5:474-479 (2003).
68. Smith S, de Lange T: TRF1, a mammalian telomeric protein. Trends Genet 13:21-26 (1997).
69. Stampfer MR, Garbe J, Levine G, Lichtsteiner S, Vasserot AP, Yaswen P: Expression of the telomerase catalytic subunit, hTERT, induces resistance to transforming growth factor beta growth inhibition in p16INK4A(-) human mammary epithelial cells. Proc Natl Acad Sci USA 98:4498-4503 (2001).
70. Stewart SA, Hahn WC, O'Connor BF, Banner EN, Lundberg AS, et al: Telomerase contributes to tumorigenesis by a telomere length-independent mechanism. Proc Natl Acad Sci USA 99:12606-12611 (2002).
71. Sung YH, Choi YS, Cheong C, Lee HW: The pleiotropy of telomerase against cell death. Mol Cells 19:303-309 (2005).
72. Taylor LM, James A, Schuller CE, Brce J, Lock RB, Mackenzie KL: Inactivation of p16INK4a, with retention of pRB and p53/p21cip1 function, in human MRC5 fibroblasts that overcome a telomere-independent crisis during immortalization. J Biol Chem 279:43634-43645 (2004).
73. Wang J, Hannon GJ, Beach DH: Risky immortalization by telomerase. Nature 405:755-756 (2000).
74. Wang YL, Qiu W, Feng HC, Li YX, Zhuang LZ, et al: Immortalization of normal human cytotrophoblast cells by reconstitution of telomeric reverse transcriptase activity. Mol Hum Reprod 12:451-460 (2006).
75. Warburg O: On the origin of cancer cells. Science 123:309-314 (1956).
76. Xu C, Jiang J, Sottile V, McWhir J, Lebkowski J, Carpenter MK: Immortalized fibroblast-like cells derived from human embryonic stem cells support undifferentiated cell growth. Stem Cells 22:972-980 (2004).
77. Yang G, Rosen DG, Colacino JA, Mercado-Uribe I, Liu J: Disruption of the retinoblastoma pathway by small interfering RNA and ectopic expression of the catalytic subunit of telomerase lead to immortalization of human ovarian surface epithelial cells. Oncogene 26:1492-1498 (2007a).
78. Yang G, Rosen DG, Mercado-Uribe I, Colacino JA, Mills GB, et al: Knockdown of p53 combined with expression of the catalytic subunit of telomerase is sufficient to immortalize primary human ovarian surface epithelial cells. Carcinogenesis 28:174-182 (2007b).
79. Yang J, Chang E, Cherry AM, Bangs CD, Oei Y, et al: Human endothelial cell life extension by telomerase expression. J Biol Chem 274:26141-26148 (1999).
80. Yang J, Nagavarapu U, Relloma K, Sjaastad MD, Moss WC, et al: Telomerized human microvasculature is functional in vivo. Nat Biotechnol 19:219-224 (2001).
81. Zongaro S, de Stanchina E, Colombo T, D'Incalci M, Giulotto E, Mondello C: Stepwise neoplastic transformation of a telomerase immortalized fibroblast cell line. Cancer Res 65:11411-11418 (2005).
82. Zongaro S, Verri A, Giulotto E, Mondello C: Telomere length and radiosensitivity in human fibroblast clones immortalized by ectopic telomerase expression. Oncol Rep 19:1605-1609 (2008).